DFT

Definium Therapeutics, Inc. Common Shares

DFTXNASDAQ

Definium Therapeutics, Inc. Common Shares is a publicly traded company trading on NASDAQ, led by CEO Robert Barrow, with a market cap of $2.1B.

Market Cap$2.1B
CEORobert Barrow
CountryUnited States of America
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
DFT

Definium Therapeutics, Inc. Common Shares FAQ

Common questions about Definium Therapeutics, Inc. Common Shares

Definium Therapeutics, Inc. Common Shares is scheduled to report earnings for Q1 2026 on May 7, 2026.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.